British academics reveal psychological barriers behind HIV testing

NewsGuard 100/100 Score

Academics from Royal Holloway, University of London, have carried out the largest global review of psychological barriers behind HIV testing and the factors that may influence people's decision to be tested.

The findings, published in the leading journal, AIDS and Behaviour, reveal fear about HIV and HIV testing is one of the biggest barriers to testing, resulting in more than half of the 35 million people infected with HIV not being diagnosed.

Dr Michael Evangeli, from the Department of Psychology at Royal Holloway, who led the study, said: "Our research shows it is imperative that more is done to reduce the fear of HIV and HIV testing to increase the amount of people being tested. A test for HIV, which can now be done in private at home, is necessary to receive HIV treatment and care. The earlier this can be done helps to reduce the onward transmission of HIV. The fact that HIV is treatable needs to be stressed."

One quarter of the over 100,000 HIV positive people in the UK, do not know that they are infected. As well as not having access to the right care and treatment these people are at risk of spreading the condition further.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Interferon-beta deficiency alters brain response in neuroHIV mouse model